Xiaozhou He
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Viral gastroenteritis research and epidemiology 7
- SARS-CoV-2 and COVID-19 Research 4
- Virology 3
Xiaozhou He
48 papers receiving 740 citations
Peers
Comparison fields: 5 of 115
- Infectious Diseases 166
- Cancer Research 119
- Genetics 63
- Nephrology 35
- Molecular Biology 320
Countries citing papers authored by Xiaozhou He
This map shows the geographic impact of Xiaozhou He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhou He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhou He more than expected).
Fields of papers citing papers by Xiaozhou He
This network shows the impact of papers produced by Xiaozhou He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhou He. The network helps show where Xiaozhou He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaozhou He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 2 | |
| 6 | 2020 | 1 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 14 | |
| 10 | 2018 | 1 | |
| 11 | 2018 | 20 | |
| 12 | 2016 | 6 | |
| 13 | 2016 | 43 | |
| 14 | 2016 | 26 | |
| 15 | [Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication]. | 2014 | 3 |
| 16 | 2014 | 98 | |
| 17 | 2014 | 7 | |
| 18 | 2013 | 2 | |
| 19 | CD256 can be found in antibody-mediated renal allograft rejection tissues. | 2012 | 5 |
| 20 | 2008 | 20 |
About Xiaozhou He
Xiaozhou He is a scholar working on Infectious Diseases, Virology, Animal Science and Zoology, Immunology and Epidemiology, having authored 51 papers that have together received 750 indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (7 papers), Immunotherapy and Immune Responses (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Animal Virus Infections Studies (4 papers), Epigenetics and DNA Methylation (4 papers), Virus-based gene therapy research (3 papers), Renal cell carcinoma treatment (3 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Infectious Diseases (166 citations), Cancer Research (119 citations), Genetics (63 citations), Nephrology (35 citations) and Molecular Biology (320 citations). Xiaozhou He has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xianlin Xu, Xuejun Ma, Dong Xue, Fengbao Luo, Xinxin Shen, Cuixing Zhou, Qianqian Shi, Ruiqing Zhang, Min Jin and Min Fan. Their work appears in journals such as Cellular Physiology and Biochemistry, China CDC Weekly, Frontiers in Bioengineering and Biotechnology, Acta Biochimica et Biophysica Sinica and Autophagy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.